What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Diabetes mellitus
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Glucagon-like peptide-1, Secretion and Receptor.
His Internal medicine research includes themes of Type 2 diabetes and Pharmacology.
All of his Endocrinology and Sulfonylurea receptor, Insulin, Glucose homeostasis, Incretin and Somatostatin investigations are sub-components of the entire Endocrinology study.
In his study, which falls under the umbrella issue of Glucagon-like peptide-1, Cell type is strongly linked to Enteroendocrine cell.
His Secretion study combines topics in areas such as Gastrointestinal hormone and Cell culture.
He has researched Receptor in several fields, including Hypothalamus and Bile acid.
His most cited work include:
- An SCN9A channelopathy causes congenital inability to experience pain (1187 citations)
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 (1041 citations)
- TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction (663 citations)
What are the main themes of his work throughout his whole career to date?
Frank Reimann spends much of his time researching Internal medicine, Endocrinology, Enteroendocrine cell, Receptor and Secretion.
His research links Type 2 diabetes with Internal medicine.
Glucagon, Glucagon-like peptide-1, Glucose homeostasis, Incretin and Diabetes mellitus are the subjects of his Endocrinology studies.
The concepts of his Enteroendocrine cell study are interwoven with issues in Intestinal mucosa, Intestinal epithelium, Peptide YY and Cell biology.
His Receptor research integrates issues from Hypothalamus and Signal transduction.
Frank Reimann interconnects Cell culture, Proglucagon and Intestinal L Cells in the investigation of issues within Secretion.
He most often published in these fields:
- Internal medicine (55.26%)
- Endocrinology (53.76%)
- Enteroendocrine cell (27.44%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (55.26%)
- Endocrinology (53.76%)
- Receptor (25.19%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Endocrinology, Receptor, Insulin and Enteroendocrine cell are his primary areas of study.
His Glucagon, Glucose homeostasis, Secretion, Diabetes mellitus and Metformin investigations are all subjects of Endocrinology research.
His research in Receptor intersects with topics in Biophysics, Glucagon-like peptide-1, Neuron, Hormone and Cell biology.
His studies in Cell biology integrate themes in fields like Intestinal epithelium and Transplantation.
His work in Insulin covers topics such as Type 2 diabetes which are related to areas like Surgery and Homeostasis.
Frank Reimann works mostly in the field of Enteroendocrine cell, limiting it down to topics relating to Peptide YY and, in certain cases, Intestinal mucosa, as a part of the same area of interest.
Between 2018 and 2021, his most popular works were:
- Glucagon-like peptide 1 (GLP-1) (164 citations)
- GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans (112 citations)
- Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. (101 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Diabetes mellitus
His primary areas of investigation include Receptor, Endocrinology, Internal medicine, Insulin and Enteroendocrine cell.
Frank Reimann combines subjects such as Transcriptome and Signal transduction, Cell biology with his study of Receptor.
As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Diabetes mellitus and frequently concerns with Gut flora.
He usually deals with Insulin and limits it to topics linked to Glucagon-like peptide-1 and Surgery.
His biological study deals with issues like Peptide YY, which deal with fields such as Intestinal mucosa.
His research integrates issues of Incretin and Neuroprotection, Pharmacology in his study of Hormone.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
